The head of the Food and Drug Administration’s drug center abruptly resigned Sunday amid concerns about his personal conduct ...
By Sarah Sorscher Last week, some of the biggest players in Big Food, including household names like Nestlé, Coca-Cola, ...
The US HHS and USDA are now tentatively targeting December for publishing the highly anticipated nutrition advice, which is ...
Casey Means, a Stanford-educated physician and wellness influencer, is set to face the Senate health committee over her ...
The Trump administration has admitted that they are not trying to identify anyone aboard boats they accuse of sending drugs ...
This analysis reviews the history and current status of biosimilar regulation in the US, concluding that changing the FDA’s interchangeability standards—as proposed by some policy makers—is a ...
Texas Attorney General Ken Paxton announced Tuesday he had filed a lawsuit against Tylenol's manufacturer, citing numerous controversial and debunked claims by Health and Human Services Secretary ...
Q3 2025 Earnings Call October 30, 2025 9:00 AM EDTCompany ParticipantsMac Livingston - Vice President of Investor ...
The United States and South Korea advanced trade talks on Wednesday, addressing details of $350 billion that would be ...
Dr. George Tidmarsh, the Food and Drug Administration’s top drug regulator, was placed on administrative leave and is ...
The director of the U.S. Food and Drug Administration's Center for Drug Evaluation and Research, George Tidmarsh, resigned on Sunday amid serious concerns about his personal conduct, a Department of ...